0310-0635 : Koselugo 5 mg Oral Granule
NDC: | 0310-0635 |
Labeler: | Astrazeneca Pharmaceuticals Lp |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Oral Granule |
Application #: | NDA219943 |
Rev. Date: |
NDC Package Codes:
- 0310-0635-60: 60 GRANULE IN 1 BOTTLE (0310‑0635‑60)
Active Ingredients:
- Selumetinib
Dosage Strength:
- 5 mg
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]
- Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0310-0610 Koselugo 10 mg Oral Capsule by Astrazeneca Pharmaceuticals Lp
- 0310-0625 Koselugo 25 mg Oral Capsule by Astrazeneca Pharmaceuticals Lp
- 0310-0640 Koselugo 7.5 mg Oral Granule by Astrazeneca Pharmaceuticals Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0310-0625Next: 0310-0640 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.